Kendrith M. Rowland

11.6k citations
188 papers · 8.5k indexed · 1 hit paper · h-index 49
Topics
Cancer Treatment and Pharmacology (32 papers)Lung Cancer Treatments and Mutations (30 papers)Colorectal Cancer Treatments and Studies (21 papers)
Partner nations
United StatesCanadaIndia

In The Last Decade

Kendrith M. Rowland

184 papers receiving 8.1k citations

Hit Papers

Phase III Study Comparing Gemcitabine Plus Cetuximab Vers...20102026201520202010100200300400500

Peers

Kendrith M. Rowland
Comparison fields: 5 of 185
  • Oncology 3.8k
  • Pulmonary and Respiratory Medicine 1.9k
  • Molecular Biology 1.5k
  • Cancer Research 866
  • Physiology 865
Replace Lesley Fallowfield with:
Lesley Fallowfield United Kingdom
Gerald F. Watts Australia
Dianne M. Finkelstein United States
Ian Olver Australia
William Grossman United States
George D. Kitas United Kingdom
Timothy J. Whelan Canada
Hyeon Chang Kim South Korea
Michael J. O’Connell United States
Otis W. Brawley United States
Kendrith M. Rowland relative to Lesley Fallowfield United Kingdom Lesley Fallowfield's profile →
Citations per field
00.5×1.5×
Lesley Fallowfield · 1×
Citations per year

Countries citing papers authored by Kendrith M. Rowland

Since Specialization
Citations

This map shows the geographic impact of Kendrith M. Rowland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kendrith M. Rowland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kendrith M. Rowland more than expected).

Fields of papers citing papers by Kendrith M. Rowland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kendrith M. Rowland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kendrith M. Rowland. The network helps show where Kendrith M. Rowland may publish in the future.

Co-authorship network of co-authors of Kendrith M. Rowland

This figure shows the co-authorship network connecting the top 25 collaborators of Kendrith M. Rowland. A scholar is included among the top collaborators of Kendrith M. Rowland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kendrith M. Rowland. Kendrith M. Rowland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 12
3 10
4 5
5 52
6 38
7 20
8 48
9 26
10 4
11
A phase II study of XL647 in patients with non-small cell lung cancer (NSCLC) enriched for presence of EGFR mutations
2
12 28
13 8
14 9
15
Research methods in human resources management
127
16
Performance evaluation, goal setting, and feedback
11
17
Research in personnel and human resources management. Supplement
36
18
Human resources management : perspectives and issues
13
19
Research in personnel and human resources management : a research annual
23
20
Current issues in personnel management
18

About Kendrith M. Rowland

Kendrith M. Rowland is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Organizational Behavior and Human Resource Management, having authored 188 papers that have together received 8.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (32 papers), Lung Cancer Treatments and Mutations (30 papers) and Colorectal Cancer Treatments and Studies (21 papers). The work is most often cited by research in Oncology (3.8k citations), Organizational Behavior and Human Resource Management (610 citations) and Pulmonary and Respiratory Medicine (1.9k citations). Kendrith M. Rowland has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Charles L. Loprinzi, Jeff A. Sloan, Gerald R. Ferris, Paul J. Novotny, Shaker R. Dakhil, Patrick J. Flynn, Tom R. Fitch, Steven R. Alberts, Aminah Jatoi and James E. Krook. Their work appears in journals such as Journal of Clinical Oncology, Blood and Academy of Management Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026